` 688278 (Xiamen Amoytop Biotech Co Ltd) vs Shanghai Composite Comparison - Alpha Spread

X
688278
vs
S
Shanghai Composite

Over the past 12 months, Xiamen Amoytop Biotech Co Ltd has outperformed Shanghai Composite, delivering a return of +17% compared to the Shanghai Composite's +15% growth.

Stocks Performance
688278 vs Shanghai Composite

Loading
688278
Shanghai Composite
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
688278 vs Shanghai Composite

Performance Gap Between 688278 and SSEC
HIDDEN
Show

Performance By Year
688278 vs Shanghai Composite

Loading
688278
Shanghai Composite
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Xiamen Amoytop Biotech Co Ltd vs Peers

Shanghai Composite
688278
ABBV
AMGN
GILD
VRTX
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Xiamen Amoytop Biotech Co Ltd
Glance View

Market Cap
33.8B CNY
Industry
Biotechnology

Xiamen Amoytop Biotech Co., Ltd., nestled in the heart of China's coastal city Xiamen, unfolds its narrative as a dynamic player in the biotechnology and healthcare industries. Born from an environment brimming with innovation, the company has diligently carved its niche by focusing on the research, development, and commercialization of diagnostic reagents and test kits. Its core competency lies in crafting solutions designed for precision and reliability, addressing the ever-evolving needs of laboratories and healthcare providers. Through a blend of cutting-edge technology and a keen understanding of biological complexities, Xiamen Amoytop has established itself as a reliable partner, providing essential tools that drive accurate diagnostics and improve patient outcomes across the globe. The company generates revenue by designing and delivering an extensive array of diagnostic products that are indispensable to modern medical practices. From infectious disease diagnostics to blood-based tests, Xiamen Amoytop leverages advancements in molecular biology to offer products that elevate the standards of health diagnostics. By supplying these critical products, the company ensures a steady flow of income sourced from healthcare facilities, research institutions, and diagnostic laboratories both domestically and internationally. Through its robust distribution network and focus on quality assurance, the company continues to expand its market presence, translating its technological prowess into financial growth and global impact.

Xiamen Amoytop Biotech Co Ltd Intrinsic Value
HIDDEN
Show
Back to Top